Mediators of Inflammation
3.545
Current Impact Factor
3.545
Current Impact Factor
90
Days
Average time from submission to acceptance
31
Days
Average time from acceptance to publication
Most Viewed Articles
| Mean platelet volume (MPV) - new perspectives for an old marker in the course and prognosis of inflammatory conditions | 45,207 |
| Anti-inflammatory properties of low and high Doxycycline doses: an in vitro study | 15,533 |
| THROMBOCYTOPENIA IN DENGUE: INTERRELATIONSHIP OF VIRUS, IMBALANCE BETWEEN COAGULATION AND FIBRINOLYSIS AND INFLAMMATORY MEDIATORS | 13,382 |
| Understand the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms | 11,245 |
| The Role of Inflammatory and Anti-inflammatory Cytokines in the Pathogenesis of Osteoarthritis | 9,908 |
| Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study | 9,330 |
| Mast cell and autoimmune diseases | 7,812 |
| Possible Immunosuppressive Effects of Drug Exposure, Environmental and Nutritional Effects on Infection and Vaccination | 7,415 |
| Cytokine levels in the serum of healthy subjects | 7,313 |
| The role of intestinal alkaline phosphatase in inflammatory disorders of gastrointestinal tract | 7,281 |
Most Viewed Special Issue Articles
| Role of histamine in modulating the immune response and inflammation | 20,036 |
| Azithromycin prevents pregnancy loss: Reducing the level of tumor necrosis factor-alpha and raising the level of interleukin -10 in rats | 14,276 |
| Increased Risk of Cancer in Relation to Gout: a Review of Three Prospective Cohort Studies with 50, 358 Subjects | 6,467 |
| The enlargement of Abdominal lymph nodes is a characteristic of autoimmune liver disease | 6,324 |
| Impact of retinoic acid on immune cells and inflammatory diseases | 5,963 |
| Anti-inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives | 5,529 |
| Evidences of herbal medicine-derived natural products effects in inflammatory lung diseases | 4,729 |
| Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Mean Platelet Volume-to-Platelet Count Ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? | 4,376 |
| Macrolide therapy in respiratory viral infections | 4,288 |
| HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes | 4,284 |
